Edge Asset Management
BIIB icon

Edge Asset Management’s Biogen BIIB Stock Holding History

Edge Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$20.2M Hold
73,945
– – 0.15% 166
2016
Q4 		$21M Sell
73,945
-1,104
-1% -$327K 0.16% 165
2016
Q3 		$23.5M Hold
75,049
– – 0.2% 158
2016
Q2 		$18.1M Buy
+75,049
New +$19.8M 0.16% 171

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Edge Asset Management's BIIB Position: Q1 2017 in Review

Edge Asset Management held its Biogen (BIIB) position steady in Q1 2017 at 73,945 shares worth $20.2M. The position accounts for 0.15% of the portfolio, ranked #166.

Edge Asset Management first reported a position in BIIB in Q2 2016 and has held it in 4 quarters since. The position peaked at $23.5M in Q3 2016. 1,020 funds tracked by Wall St. Rank hold BIIB as of Q1 2017.

  • Edge Asset Management held 73,945 shares of Biogen worth $20.2M as of Q1 2017.
  • Edge Asset Management left its Biogen share count unchanged in Q1 2017.
  • Biogen made up 0.15% of Edge Asset Management's portfolio in Q1 2017, its #166 holding.
  • Edge Asset Management first reported a position in Biogen in Q2 2016 and has held it in 4 quarters since.
  • Edge Asset Management's Biogen position peaked at $23.5M in Q3 2016.
  • 1,020 funds tracked by Wall St. Rank held Biogen as of Q1 2017.

Based on Edge Asset Management's 13F filing for Q1 2017, filed 11 May 2017.